Washburn Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Washburn Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-625	Closed	-$317K	–	50
2023 Q3	$317K	Hold	625	–	–	0.27%	38
2023 Q2	$326K	Sell	625 -325	-34%	-$175K	0.27%	38
2023 Q1	$548K	Buy	950 +6	+0.6%	+$3.38K	0.47%	34
2022 Q4	$520K	Sell	944 -10	-1%	-$5.3K	0.47%	33
2022 Q3	$484K	Sell	954 -40	-4%	-$22.4K	0.46%	31
2022 Q2	$540K	Sell	994 -5	-0.5%	-$2.75K	0.47%	35
2022 Q1	$590K	Sell	999 -166	-14%	-$95.4K	0.39%	38
2021 Q4	$777K	Sell	1,165 -20	-2%	-$12.5K	0.46%	30
2021 Q3	$677K	Sell	1,185 -145	-11%	-$79.6K	0.44%	36
2021 Q2	$671K	Sell	1,330 -10	-0.7%	-$4.72K	0.45%	35
2021 Q1	$612K	Buy	1,340 +75	+6%	+$35.8K	0.42%	39
2020 Q4	$589K	Buy	1,265 +90	+8%	+$42.2K	0.41%	39
2020 Q3	$519K	Buy	+1,175	New	+$485K	0.41%	35

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Washburn Capital Management's TMO Position: Q4 2023 in Review

Washburn Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 625 shares — an estimated $317K sold.

Washburn Capital Management first reported a position in TMO in Q3 2020 and held it in 13 quarters. The position peaked at $777K in Q4 2021. 2,490 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Washburn Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Washburn Capital Management sold 625 Thermo Fisher Scientific shares in Q4 2023, an estimated $317K.
Washburn Capital Management first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 13 quarters.
Washburn Capital Management's Thermo Fisher Scientific position peaked at $777K in Q4 2021.
2,490 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Washburn Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.